Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/96157
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | López-Ogalla, Javier | - |
dc.contributor.author | García-Palomero, Esther | - |
dc.contributor.author | Sánchez-Quesada, Jorge | - |
dc.contributor.author | Rubio, Laura | - |
dc.contributor.author | Delgado, Elena | - |
dc.contributor.author | García, Pablo | - |
dc.contributor.author | Medina, Miguel | - |
dc.contributor.author | Castro, Ana | - |
dc.contributor.author | Muñoz, Pilar | - |
dc.date.accessioned | 2014-05-05T09:09:46Z | - |
dc.date.available | 2014-05-05T09:09:46Z | - |
dc.date.issued | 2014 | - |
dc.identifier | doi: 10.1039/c3md00236e | - |
dc.identifier | issn: 2040-2511 | - |
dc.identifier | e-issn: 2040-2511 | - |
dc.identifier.citation | MedChemComm 5: 474- 488 (2014) | - |
dc.identifier.uri | http://hdl.handle.net/10261/96157 | - |
dc.description.abstract | Abnormal accumulation of neurotoxic beta-amyloid peptides (Aβ) is a key factor in the development of Alzheimer's disease (AD) and strategies to reduce Aβ production constitute an active field of research for the development of novel therapeutic agents for the treatment of AD. In particular, β-secretase-1 (BACE-1) has been a prime target for modulating Aβ production although obtaining drug-like BACE-1 inhibitors has proven to be highly challenging. Here we report the isolation and biochemical characterization of a marine natural product, the prenylated hydroxybenzoic acid 1, with BACE-1 inhibitory activity and ability to decrease Aβ production in cell-based assays. Synthesis and biological activity of a number of new synthetic analogues are also reported, as well as initial structure-activity relationship (SAR) analysis on this chemical family. Hence, these compounds constitute novel scaffolds from which more potent and selective BACE-1 inhibitors could be designed as potential therapeutic agents for the treatment of Alzheimer's disease. © 2014 the Partner Organisations. | - |
dc.rights | closedAccess | - |
dc.title | Bioactive prenylated phenyl derivatives derived from marine natural products: Novel scaffolds for the design of BACE inhibitors | - |
dc.type | artículo | - |
dc.identifier.doi | 10.1039/c3md00236e | - |
dc.date.updated | 2014-05-05T09:09:46Z | - |
dc.description.version | Peer Reviewed | - |
dc.language.rfc3066 | eng | - |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | es_ES |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.openairetype | artículo | - |
Aparece en las colecciones: | (IQM) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
7
checked on 13-abr-2024
WEB OF SCIENCETM
Citations
6
checked on 19-feb-2024
Page view(s)
337
checked on 22-abr-2024
Download(s)
99
checked on 22-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.